Ventas ups ATM equity capacity to $3.0B; all 12 directors elected at annual meeting

Ventas, Inc.

Amendment No. 3 to ATM Sales Agreement raises aggregate gross sales price to $3.0B, excluding prior sales.
Annual meeting had 93.5% voter turnout; all 12 director nominees elected with majority votes.
Say-on-pay proposal approved with 91.6% of votes cast in favor; KPMG ratification passed.
EVP Peter J. Bulgarelli retired May 1, 2026; separation agreement provides prorated 2026 bonus subject to release and restrictive covenants.

item 5.02item 5.07item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Peter J. Bulgarelli

Executive Vice President, Outpatient Medical & Research

VTR · Ventas, Inc.

Effective: 2026-05-01
Filed: May 15, 2026 21:15 UTC

On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc.

Source: SEC EDGAR

accession 0001104659-26-062795

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.